Gene: TXNRD1
Official Full Name: thioredoxin reductase 1provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes an ubiquitously expressed, cytosolic form of TrxR, which functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternative splicing, primarily at the 5' end, results in transcript variants encoding same or different isoforms, including a glutaredoxin-containing isoform that is predominantly expressed in testis. [provided by RefSeq, May 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06517 | TXNRD1 Knockout cell line (HeLa) | Human | TXNRD1 | 1:3~1:6 | Negative | Online Inquiry |
KO06518 | TXNRD1 Knockout cell line (HCT 116) | Human | TXNRD1 | 1:2~1:4 | Negative | Online Inquiry |
KO06519 | TXNRD1 Knockout cell line (HEK293) | Human | TXNRD1 | 1:3~1:6 | Negative | Online Inquiry |
KO06520 | TXNRD1 Knockout cell line (A549) | Human | TXNRD1 | 1:3~1:4 | Negative | Online Inquiry |
TXNRD1 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the thioredoxin reductase 1 (TXNRD1) gene by providing a robust experimental framework for gene function analysis. These knockout cell lines are developed using advanced CRISPR/Cas9 gene-editing technology, ensuring precise deletion of the TXNRD1 gene while minimizing off-target effects. By creating a cellular environment devoid of this critical gene, researchers can investigate its biological roles, regulatory mechanisms, and implications in various physiological and pathological conditions.
The key function of TXNRD1 is its involvement in redox homeostasis and cellular antioxidant defense systems. It plays a pivotal role in maintaining the balance between oxidants and antioxidants inside cells, thus protecting against oxidative stress and related cellular damage. This function is particularly crucial in cancer cells, where proliferation is often linked to altered redox states, and in neurodegenerative diseases where oxidative damage contributes to neuronal degeneration. The TXNRD1 gene knockout cell lines provide a unique opportunity to explore these pathways, offering insights that could lead to novel therapeutic strategies.
Scientifically, the importance of these cell lines cannot be overstated. They serve as a powerful tool in both research and clinical settings, enabling the dissection of TXNRD1's role in disease progression and potential drug responses. Researchers can utilize these models to validate drug targets, test new therapeutic compounds, and understand the molecular mechanisms underlying various health issues, from cancer to aging.
Compared to existing models, TXNRD1 Gene Knockout Cell Lines stand out due to their specificity and reliability. Many conventional cell lines possess endogenous levels of TXNRD1, which can confound experimental results. Our knockout models eliminate this variable, providing more accurate data and enhancing reproducibility across experiments. Furthermore, they are compatible with various assays, including bioenergetic assessments, proliferation studies, and drug response evaluations.
For researchers and clinicians alike, the value of TXNRD1 Gene Knockout Cell Lines is in their ability to bridge the gap between basic research and clinical applications. These cell lines allow users to conduct high-quality, focused studies that can directly inform therapeutic development and clinical strategies.
At [Your Company Name], we pride ourselves on our commitment to advancing biological research through innovative solutions. Our expertise in gene editing and cellular model development ensures that our products, including the TXNRD1 Gene Knockout Cell Lines, meet the highest standards of quality and provide invaluable resources to the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.